RxDoctor Payments DataLook up a doctor →

Rashmee Patil

Hepatology · McAllen, TXNPI 1780943860

Payments from drug & device makers

$3,284,744in general payments, 2019–2025

Across 679 payments — averaging $4837.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$1.8M
  • Boehringer Ingelheim International GmbH$592K
  • Madrigal Pharmaceuticals$565K
  • Genentech, Inc.$116K
  • GSK$61K
  • Novo Nordisk$47K
  • plus $76K from 8 others
$187in research payments, 2019–2025

Across 1 payment — averaging $187.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$187

What the payments were for

  • Consulting fees$46,33532%
  • Speaking & faculty fees$87,69360%
  • Travel & lodging$7,9935%
  • Food & beverage$3,9003%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,284,744 in reported general payments places this provider in the 95th percentile of 22 hepatology providers in Texas.

See all hepatology providers in Texas

Other hepatology in McAllen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →